Trial
NCT01037959
Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Cirrhosis
Intervention
Norfloxacin
Why stopped
lack of recruitement
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-09